Icli, F. Et Al. 1998. A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. CANCER , vol.83, no.12 , 2475-2480.

Icli, F., ÇELİK, İ., Aykan, F., Uner, A., DEMİRKAZIK, A., Ozet, A., ... Ozguroglu, M.(1998). A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma. CANCER , vol.83, no.12, 2475-2480.

Icli, F Et Al. "A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma," CANCER , vol.83, no.12, 2475-2480, 1998

Icli, F Et Al. "A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma." CANCER , vol.83, no.12, pp.2475-2480, 1998

Icli, F. Et Al. (1998) . "A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma." CANCER , vol.83, no.12, pp.2475-2480.

@article{article, author={F Icli Et Al. }, title={A randomized phase III trial of etoposide, epirubicin, and cisplatin versus 5-fluorouracil, epirubicin, and cisplatin in the treatment of patients with advanced gastric carcinoma}, journal={CANCER}, year=1998, pages={2475-2480} }